{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:27:27Z","timestamp":1786973247472,"version":"build-2736575974"},"reference-count":59,"publisher":"Harborside Press, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>This review summarizes the current NCCN recommendations for the surgical management of pleural mesothelioma, highlighting the clinical trials and retrospective analyses that have shaped current practice and informed guideline recommendations. Advances in systemic therapy, surgical technique, and radiation therapy have shifted management toward multidisciplinary care. Contemporary treatment paradigms emphasize the importance of histology, stage, performance status, and institutional expertise when considering surgical intervention. Surgery can still be considered part of the multimodality treatment strategy in carefully selected patients, despite recent evidence suggesting its possible lack of benefit. Further investigation is required to improve patient stratification, refine multimodal regimens, and develop novel therapeutic approaches. This review aims to provide a contemporary framework for understanding the current role of surgery within the broader management of pleural mesothelioma.<\/jats:p>","DOI":"10.6004\/jnccn.2026.7059","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:56:01Z","timestamp":1786971361000},"source":"Crossref","is-referenced-by-count":0,"title":["Current Surgical Perspectives for Pleural Mesothelioma"],"prefix":"10.6004","volume":"24","author":[{"given":"Simon","family":"Esteva","sequence":"first","affiliation":[{"name":"Department of Surgery, University of California Los Angeles, Los Angeles, CA"},{"name":"Division of Thoracic Surgery, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Abtin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Lab Medicine, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Fishbein","sequence":"additional","affiliation":[{"name":"Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Cameron","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California Los Angeles, Los Angeles, CA"},{"name":"Division of Thoracic Surgery, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Burt","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California Los Angeles, Los Angeles, CA"},{"name":"Division of Thoracic Surgery, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Yanagawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California Los Angeles, Los Angeles, CA"},{"name":"Division of Thoracic Surgery, University of California Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Carcinogenesis","first-page":"529","article-title":"Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database","volume":"40","author":"Van Gerwen M","year":"2019","unstructured":"Van Gerwen M, Alpert N, Wolf A,  Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database. Carcinogenesis 2019;40:529\u2013536."},{"key":"B2","series-title":"Cancers (Basel)","first-page":"1719","article-title":"The role of surgery in pleural mesothelioma","volume":"16","author":"Lapidot M","year":"2024","unstructured":"Lapidot M, Sattler M. The role of surgery in pleural mesothelioma. Cancers (Basel) 2024;16:1719."},{"key":"B3","series-title":"Cancers (Basel)","first-page":"3199","article-title":"Perioperative treatments in pleural mesothelioma: state of the art and future directions","volume":"17","author":"Cecchi LG","year":"2025","unstructured":"Cecchi LG, Aliprandi M, De Vincenzo F,  Perioperative treatments in pleural mesothelioma: state of the art and future directions. Cancers (Basel) 2025;17:3199."},{"key":"B4","article-title":"NCCN Clinical Practice Guidelines in Oncology: Mesothelioma: Pleural. Version 2.2026","author":"Riely GJ","unstructured":"Riely GJ, Wood DE, Stevenson J,  NCCN Clinical Practice Guidelines in Oncology: Mesothelioma: Pleural. Version 2.2026. Accessed June 25, 2026. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B5","series-title":"J Thorac Cardiovasc Surg","first-page":"1584","article-title":"Survival results in biphasic malignant pleural mesothelioma patients: a multicentric analysis","volume":"159","author":"Lococo F","year":"2020","unstructured":"Lococo F, Torricelli F, Lang-Lazdunski L,  Survival results in biphasic malignant pleural mesothelioma patients: a multicentric analysis. J Thorac Cardiovasc Surg 2020;159:1584\u20131593.e2."},{"key":"B6","series-title":"J Clin Oncol","first-page":"1343","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler HL","year":"2018","unstructured":"Kindler HL, Ismaila N, Armato SG,  Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2018;36:1343\u20131373."},{"key":"B7","series-title":"J Clin Oncol","first-page":"1006","article-title":"Treatment of pleural mesothelioma: ASCO guideline update","volume":"43","author":"Kindler HL","year":"2025","unstructured":"Kindler HL, Ismaila N, Bazhenova L,  Treatment of pleural mesothelioma: ASCO guideline update. J Clin Oncol 2025;43:1006\u20131038."},{"key":"B8","series-title":"Eur Respir J","first-page":"1900953","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel A","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T,  ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J 2020;55:1900953."},{"key":"B9","series-title":"J Thorac Cardiovasc Surg","first-page":"1340","article-title":"Outcomes of pleurectomy decortication in patients with biphasic mesothelioma","volume":"164","author":"Lapidot M","year":"2022","unstructured":"Lapidot M, Mazzola E, Bueno R. Outcomes of pleurectomy decortication in patients with biphasic mesothelioma. J Thorac Cardiovasc Surg 2022;164:1340\u20131348.e3."},{"key":"B10","series-title":"Arch Pathol Lab Med","first-page":"1251","article-title":"Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the International Mesothelioma Interest Group","volume":"148","author":"Husain AN","year":"2024","unstructured":"Husain AN, Chapel DB, Attanoos R,  Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2024;148:1251\u20131271."},{"key":"B11","series-title":"Int J Occup Environ Health","first-page":"398","article-title":"Incidence and descriptive epidemiology of mesothelioma in the United States, 1999\u20132002","volume":"13","author":"Larson T","year":"2007","unstructured":"Larson T, Melnikova N, Davis SI, Jamison P. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999\u20132002. Int J Occup Environ Health 2007;13:398\u2013403."},{"key":"B12","series-title":"Ann Oncol","first-page":"129","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"33","author":"Popat S","year":"2022","unstructured":"Popat S, Baas P, Faivre-Finn C,  Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2022;33:129\u2013142."},{"key":"B13","series-title":"Mod Pathol","first-page":"1383","article-title":"Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma","volume":"35","author":"Chapel DB","year":"2022","unstructured":"Chapel DB, Hornick JL, Barlow J,  Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma. Mod Pathol 2022;35:1383\u20131397."},{"key":"B14","series-title":"JTCVS Open","first-page":"318","article-title":"Potential advantage of magnetic resonance imaging in detecting thoracic wall infiltration in pleural mesothelioma: a retrospective single-center analysis","volume":"23","author":"Barreto I","year":"2025","unstructured":"Barreto I, Franckenberg S, Frauenfelder T,  Potential advantage of magnetic resonance imaging in detecting thoracic wall infiltration in pleural mesothelioma: a retrospective single-center analysis. JTCVS Open 2025;23:318\u2013325."},{"key":"B15","series-title":"AJR Am J Roentgenol","first-page":"W125","article-title":"Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes","volume":"195","author":"Gill RR","year":"2010","unstructured":"Gill RR, Umeoka S, Mamata H,  Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol 2010;195:W125\u2013130."},{"key":"B16","series-title":"Ann Surg","first-page":"577","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients","volume":"260","author":"Sugarbaker DJ","year":"2014","unstructured":"Sugarbaker DJ, Richards WG, Bueno R. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Ann Surg 2014;260:577."},{"key":"B17","series-title":"Eur J Cardiothorac Surg","first-page":"497","article-title":"The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma","volume":"25","author":"Pilling JE","year":"2004","unstructured":"Pilling JE, Stewart DJ, Martin-Ucar AE,  The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2004;25:497\u2013501."},{"key":"B18","series-title":"Ann Thorac Surg","first-page":"862","article-title":"Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma","volume":"88","author":"Rice DC","year":"2009","unstructured":"Rice DC, Steliga MA, Stewart J,  Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 2009;88:862\u2013869."},{"key":"B19","series-title":"Lancet Oncol","first-page":"763","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure T","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D,  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763\u2013772."},{"key":"B20","series-title":"J Thorac Cardiovasc Surg","first-page":"138","article-title":"Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies","volume":"128","author":"Sugarbaker DJ","year":"2004","unstructured":"Sugarbaker DJ, Jaklitsch MT, Bueno R,  Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004;128:138\u2013146."},{"key":"B21","series-title":"N Engl J Med","first-page":"1207","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Janes SM","year":"2021","unstructured":"Janes SM, Alrifai D, Fennell DA. Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med 2021;385:1207\u20131218."},{"key":"B22","series-title":"Ann Surg Oncol","first-page":"2037","article-title":"Landmark trials in the surgical management of mesothelioma","volume":"28","author":"Kantor T","year":"2021","unstructured":"Kantor T, Wakeam E. Landmark trials in the surgical management of mesothelioma. Ann Surg Oncol 2021;28:2037\u20132047."},{"key":"B23","series-title":"Lancet Respir Med","first-page":"457","article-title":"Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial","volume":"12","author":"Lim E","year":"2024","unstructured":"Lim E, Waller D, Lau K,  Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial. Lancet Respir Med 2024;12:457\u2013466."},{"key":"B24","series-title":"Ann Surg","first-page":"1212","article-title":"Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experience in 355 consecutive patients","volume":"275","author":"Lapidot M","year":"2022","unstructured":"Lapidot M, Gill RR, Mazzola E,  Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experience in 355 consecutive patients. Ann Surg 2022;275:1212\u20131220."},{"key":"B25","series-title":"J Thorac Oncol","first-page":"262","article-title":"A perspective on the MARS2 trial","volume":"20","author":"Lim E","year":"2025","unstructured":"Lim E, Opitz I, Woodard G,  A perspective on the MARS2 trial. J Thorac Oncol 2025;20:262\u2013272."},{"key":"B26","series-title":"Lung Cancer","first-page":"241","article-title":"Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections","volume":"81","author":"B\u00f6l\u00fckbas S","year":"2013","unstructured":"B\u00f6l\u00fckbas S, Eberlein M, Fisseler-Eckhoff A, Schirren J. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections. Lung Cancer 2013;81:241\u2013246."},{"key":"B27","series-title":"J Thorac Oncol","first-page":"1304","article-title":"Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group","volume":"6","author":"Rice D","year":"2011","unstructured":"Rice D, Rusch V, Pass H,  Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol 2011;6:1304\u20131312."},{"key":"B28","series-title":"J Thorac Oncol","first-page":"737","article-title":"Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma","volume":"7","author":"Lang-Lazdunski L","year":"2012","unstructured":"Lang-Lazdunski L, Bille A, Lal R,  Pleurectomy\/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 2012;7:737\u2013743."},{"key":"B29","series-title":"Transl Lung Cancer Res","first-page":"190","article-title":"Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma","volume":"12","author":"Lapidot M","year":"2023","unstructured":"Lapidot M, Bueno R. Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma. Transl Lung Cancer Res 2023;12:190\u2013192."},{"key":"B30","series-title":"Lung Cancer","first-page":"240","article-title":"A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao C","year":"2014","unstructured":"Cao C, Tian D, Park J,  A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 2014;83:240\u2013245."},{"key":"B31","series-title":"Ann Thorac Surg","first-page":"200","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication for malignant pleural mesothelioma","volume":"113","author":"Zhou N","year":"2022","unstructured":"Zhou N, Rice DC, Tsao AS,  Extrapleural pneumonectomy versus pleurectomy\/decortication for malignant pleural mesothelioma. Ann Thorac Surg 2022;113:200\u2013208."},{"key":"B32","series-title":"Clin Chest Med","first-page":"181","article-title":"Malignant pleural effusion: from diagnostics to therapeutics","volume":"39","author":"Asciak R","year":"2018","unstructured":"Asciak R, Rahman NM. Malignant pleural effusion: from diagnostics to therapeutics. Clin Chest Med 2018;39:181\u2013193."},{"key":"B33","series-title":"Ann Thorac Surg","first-page":"1053","article-title":"Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions","volume":"94","author":"Hunt BM","year":"2012","unstructured":"Hunt BM, Farivar AS, Valli\u00e8res E,  Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg 2012;94:1053\u20131057; discussion 1057\u20131059."},{"key":"B34","series-title":"Lancet","first-page":"1118","article-title":"Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial","volume":"384","author":"Rintoul RC","year":"2014","unstructured":"Rintoul RC, Ritchie AJ, Edwards JG,  Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet 2014;384:1118\u20131127."},{"key":"B35","series-title":"Lung Cancer","first-page":"75","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy","volume":"71","author":"B\u00f6l\u00fckbas S","year":"2011","unstructured":"B\u00f6l\u00fckbas S, Manegold C, Eberlein M,  Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy. Lung Cancer 2011;71:75\u201381."},{"key":"B36","series-title":"J Clin Oncol","first-page":"1413","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"De Perrot M","year":"2009","unstructured":"De Perrot M, Feld R, John Cho BC,  Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:1413\u20131418."},{"key":"B37","series-title":"Radiat Oncol","first-page":"267","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"Thieke C","year":"2015","unstructured":"Thieke C, Nicolay NH, Sterzing F,  Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy. Radiat Oncol 2015;10:267."},{"key":"B38","series-title":"J Clin Oncol","first-page":"3007","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug LM","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW,  Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007\u20133013."},{"key":"B39","series-title":"J Thorac Oncol","first-page":"499","article-title":"Trimodality treatment of malignant pleural mesothelioma","volume":"3","author":"Batirel HF","year":"2008","unstructured":"Batirel HF, Metintas M, Caglar HB,  Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 2008;3:499\u2013504."},{"key":"B40","series-title":"Transl Lung Cancer Res","first-page":"593","article-title":"A randomized phase II study of pleurectomy\/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)","volume":"7","author":"Raskin J","year":"2018","unstructured":"Raskin J, Surmont V, Cornelissen R,  A randomized phase II study of pleurectomy\/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205). Transl Lung Cancer Res 2018;7:593\u2013598."},{"key":"B41","series-title":"J Clin Oncol","first-page":"2761","article-title":"Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rimner A","year":"2016","unstructured":"Rimner A, Zauderer MG, Gomez DR,  Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma. J Clin Oncol 2016;34:2761\u20132768."},{"key":"B42","series-title":"Lancet Oncol","first-page":"1651","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel RA","year":"2015","unstructured":"Stahel RA, Riesterer O, Xyrafas A,  Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol 2015;16:1651\u20131658."},{"key":"B43","series-title":"Crit Rev Oncol Hematol","first-page":"103278","article-title":"Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: a systematic review and meta-analysis of randomized trials","volume":"160","author":"Lee CC","year":"2021","unstructured":"Lee CC, Soon YY, Vellayappan B,  Prophylactic irradiation of tracts in patients with malignant pleural mesothelioma: a systematic review and meta-analysis of randomized trials. Crit Rev Oncol Hematol 2021;160:103278."},{"key":"B44","series-title":"Chest","first-page":"754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy","volume":"108","author":"Boutin C","year":"1995","unstructured":"Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754\u2013758."},{"key":"B45","series-title":"Lancet Oncol","first-page":"1094","article-title":"Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial","volume":"17","author":"Clive AO","year":"2016","unstructured":"Clive AO, Taylor H, Dobson L,  Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol 2016;17:1094\u20131104."},{"key":"B46","series-title":"J Vasc Interv Radiol","first-page":"S139","article-title":"Role of percutaneous cryoablation in management of recurrent mesothelioma following lung sparing pleurectomy and decortications","volume":"24","author":"Abtin F","year":"2013","unstructured":"Abtin F, Suh R, Sandberg J,  Role of percutaneous cryoablation in management of recurrent mesothelioma following lung sparing pleurectomy and decortications. J Vasc Interv Radiol 2013;24:S139."},{"key":"B47","series-title":"Lancet","first-page":"375","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas P","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK,  First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet 2021;397:375\u2013386."},{"key":"B48","series-title":"Lancet","first-page":"2295","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial","volume":"402","author":"Chu Q","year":"2023","unstructured":"Chu Q, Perrone F, Greillier L,  Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. Lancet 2023;402:2295\u20132306."},{"key":"B49","series-title":"Clin Lung Cancer","first-page":"142","article-title":"A phase II trial of nivolumab with chemotherapy followed by maintenance nivolumab in patients with pleural mesothelioma after surgery: the NICITA study protocol","volume":"22","author":"Shah R","year":"2021","unstructured":"Shah R, Klotz LV, Chung I,  A phase II trial of nivolumab with chemotherapy followed by maintenance nivolumab in patients with pleural mesothelioma after surgery: the NICITA study protocol. Clin Lung Cancer 2021;22:142\u2013146."},{"key":"B50","series-title":"Nat Med","first-page":"4097","article-title":"Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses","volume":"31","author":"Reuss JE","year":"2025","unstructured":"Reuss JE, Lee PK, Mehran RJ,  Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses. Nat Med 2025;31:4097\u20134108."},{"key":"B51","series-title":"Clin Cancer Res","first-page":"548","article-title":"A phase II window of opportunity study of neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 blockade for patients with malignant pleural mesothelioma","volume":"29","author":"Lee HS","year":"2023","unstructured":"Lee HS, Jang HJ, Ramineni M,  A phase II window of opportunity study of neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 blockade for patients with malignant pleural mesothelioma. Clin Cancer Res 2023;29:548\u2013559."},{"key":"B52","series-title":"Thorac Surg Clin","first-page":"549","article-title":"Innovative therapies: intraoperative intracavitary chemotherapy","volume":"14","author":"Chang MY","year":"2004","unstructured":"Chang MY, Sugarbaker DJ. Innovative therapies: intraoperative intracavitary chemotherapy. Thorac Surg Clin 2004;14:549\u2013556."},{"key":"B53","series-title":"J Thorac Cardiovasc Surg","first-page":"955","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker DJ","year":"2013","unstructured":"Sugarbaker DJ, Gill RR, Yeap BY,  Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg 2013;145:955\u2013963."},{"key":"B54","series-title":"J Thorac Cardiovasc Surg","first-page":"405","article-title":"Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study","volume":"138","author":"Tilleman TR","year":"2009","unstructured":"Tilleman TR, Richards WG, Zellos L,  Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009;138:405\u2013411."},{"key":"B55","series-title":"Cancers (Basel)","first-page":"1160","article-title":"Malignant pleural mesothelioma: from pathophysiology to innovative actionable targets","volume":"17","author":"Bertuccio FR","year":"2025","unstructured":"Bertuccio FR, Montini S, Fusco MA,  Malignant pleural mesothelioma: from pathophysiology to innovative actionable targets. Cancers (Basel) 2025;17:1160."},{"key":"B56","series-title":"NPJ Precis Oncol","first-page":"133","article-title":"NF2: an underestimated player in cancer metabolic reprogramming and tumor immunity","volume":"8","author":"Xu D","year":"2024","unstructured":"Xu D, Yin S, Shu Y. NF2: an underestimated player in cancer metabolic reprogramming and tumor immunity. NPJ Precis Oncol 2024;8:133."},{"key":"B57","series-title":"BMC Cancer","first-page":"507","article-title":"CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure","volume":"19","author":"Kettunen E","year":"2019","unstructured":"Kettunen E, Savukoski S, Salmenkivi K,  CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure. BMC Cancer 2019;19:507."},{"key":"B58","series-title":"Biomark Res","first-page":"11","article-title":"Anti-mesothelin CAR T cell therapy for malignant mesothelioma","volume":"9","author":"Castelletti L","year":"2021","unstructured":"Castelletti L, Yeo D, Van Zandwijk N, Rasko JEJ. Anti-mesothelin CAR T cell therapy for malignant mesothelioma. Biomark Res 2021;9:11."},{"key":"B59","series-title":"Cancer Discov","first-page":"2748","article-title":"A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti\u2013PD-1 agent pembrolizumab","volume":"11","author":"Adusumilli PS","year":"2021","unstructured":"Adusumilli PS, Zauderer MG, Rivi\u00e8re I,  A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti\u2013PD-1 agent pembrolizumab. Cancer Discov 2021;11:2748\u20132763."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/8\/article-e267059.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/8\/article-e267059.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/8\/article-e267059.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:56:01Z","timestamp":1786971361000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/8\/article-e267059.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":59,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2026.7059","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}